Published in Fertil Steril on July 01, 2009
Anti-Mullerian Hormone as Predictor of Ovarian Responce to Clomiphene Citrate in PCOS | NCT03316469
Ontogeny of the ovary in polycystic ovary syndrome. Fertil Steril (2013) 0.92
Early prenatal androgenization results in diminished ovarian reserve in adult female rhesus monkeys. Hum Reprod (2009) 0.81
A novel approach to quantifying ovarian cell lipid content and lipid accumulation in vitro by confocal microscopy in lean women undergoing ovarian stimulation for in vitro fertilization (IVF). J Assist Reprod Genet (2013) 0.78
21-Hydroxylase-derived steroids in follicles of nonobese women undergoing ovarian stimulation for in vitro fertilization (IVF) positively correlate with lipid content of luteinized granulosa cells (LGCs) as a source of cholesterol for steroid synthesis. J Clin Endocrinol Metab (2014) 0.77
Intrafollicular cortisol levels inversely correlate with cumulus cell lipid content as a possible energy source during oocyte meiotic resumption in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril (2014) 0.77
Anti-Müllerian hormone as a predictor of polycystic ovary syndrome treated with clomiphene citrate. Clin Exp Reprod Med (2016) 0.75
Evaluation of ovarian reserve after laparoscopic surgery in patients with polycystic ovary syndrome. Bioimpacts (2012) 0.75
Effect of Anti-Müllerian hormone (AMH) and bone morphogenetic protein 15 (BMP-15) on steroidogenesis in primary-cultured human luteinizing granulosa cells through Smad5 signalling. J Assist Reprod Genet (2015) 0.75
Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod (2004) 3.57
Anti-Müllerian hormone: a new marker for ovarian function. Reproduction (2006) 2.49
Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab (1996) 2.37
Anti-Müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization. Fertil Steril (2007) 2.37
Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril (2002) 2.10
Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril (2006) 1.75
Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology (1995) 1.66
Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod (2003) 1.61
Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab (2006) 1.59
Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females. Clin Endocrinol (Oxf) (2005) 1.57
Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance. Fertil Steril (2007) 1.51
Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod (2005) 1.45
Nongenomic effects of 17 beta-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J Clin Endocrinol Metab (1995) 1.36
Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum Reprod (2006) 1.26
Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women. Hum Reprod (2007) 1.23
Local roles of TGF-beta superfamily members in the control of ovarian follicle development. Anim Reprod Sci (2003) 1.22
Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil Steril (2007) 1.21
Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril (2008) 1.19
Anti-Müllerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization. J Clin Endocrinol Metab (2007) 1.16
Estradiol and regulation of anti-Müllerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid. J Clin Endocrinol Metab (2006) 1.09
Oocyte regulation of anti-Müllerian hormone expression in granulosa cells during ovarian follicle development in mice. Dev Biol (2004) 1.06
Expression of anti-Mullerian hormone protein during early follicular development in the primate ovary in vivo is influenced by suppression of gonadotropin secretion and inhibition of vascular endothelial growth factor. Endocrinology (2007) 1.01
Per-follicle measurements indicate that anti-müllerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status. Fertil Steril (2005) 0.98
Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity. Endocrinology (1992) 0.97
Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization. J Clin Endocrinol Metab (2006) 0.97
Stage-specific expression of androgen receptor, follicle-stimulating hormone receptor, and anti-Müllerian hormone type II receptor in single, isolated, human preantral follicles: relevance to polycystic ovaries. J Clin Endocrinol Metab (2006) 0.95
The inhibitory effects of müllerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells. J Clin Endocrinol Metab (1992) 0.88
Insulin and messenger ribonucleic acid expression of insulin receptor isoforms in ovarian follicles from nonhirsute ovulatory women and polycystic ovary syndrome patients. J Clin Endocrinol Metab (2004) 0.87
Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily. Mol Endocrinol (1993) 0.87
Müllerian inhibiting substance as oocyte meiosis inhibitor. Mol Cell Endocrinol (1986) 0.83
Human recombinant mullerian inhibiting substance inhibition of rat oocyte meiosis is reversed by epidermal growth factor in vitro. Endocrinology (1988) 0.83
Müllerian inhibiting substance gene expression in the cycling rat ovary correlates with recruited or graafian follicle selection. Biol Reprod (1994) 0.82
Differential effects of epidermal growth factor, somatomedin-C/insulin-like growth factor I, and transforming growth factor-beta on porcine granulosa cell deoxyribonucleic acid synthesis and cell proliferation. Endocrinology (1988) 0.81
Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating hormone. Fertil Steril (2005) 0.80
Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid müllerian-inhibiting substance and androgen content. J Clin Endocrinol Metab (1993) 0.80
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol (2013) 9.43
High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet (2005) 6.86
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA (2006) 4.26
Brain β-amyloid load approaches a plateau. Neurology (2013) 2.50
Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion (2006) 2.45
Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol (2006) 1.77
Determinants of medical system delay in the diagnosis of colorectal cancer within the Veteran Affairs Health System. Dig Dis Sci (2010) 1.68
Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord (2007) 1.61
Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease. Am J Med Genet B Neuropsychiatr Genet (2005) 1.60
Reproduction in captive common marmosets (Callithrix jacchus). Comp Med (2003) 1.59
UCHL1 is a Parkinson's disease susceptibility gene. Ann Neurol (2004) 1.54
Environmental factors and puberty timing: expert panel research needs. Pediatrics (2008) 1.54
Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys. J Nutr (2002) 1.51
Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab (2006) 1.51
Shapes of the trajectories of 5 major biomarkers of Alzheimer disease. Arch Neurol (2012) 1.44
Quality of nonmetastatic colorectal cancer care in the Department of Veterans Affairs. J Clin Oncol (2010) 1.43
The Aging Game: improving medical students' attitudes toward caring for the elderly. J Am Med Dir Assoc (2005) 1.35
Surgical stage I endometrial cancer: predictors of distant failure and death. Gynecol Oncol (2002) 1.30
Effect of lifestyle activities on Alzheimer disease biomarkers and cognition. Ann Neurol (2012) 1.28
Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics. Trends Neurosci (2009) 1.24
The natural history of recurrent optic neuritis. Arch Neurol (2004) 1.22
Developmental programming: impact of excess prenatal testosterone on intrauterine fetal endocrine milieu and growth in sheep. Biol Reprod (2010) 1.15
Reliability of self-reported ancestry among siblings: implications for genetic association studies. Am J Epidemiol (2006) 1.14
Standardization of grading embryo morphology. Fertil Steril (2010) 1.13
Standardization of grading embryo morphology. J Assist Reprod Genet (2010) 1.12
Increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation. Obes Res (2003) 1.12
Parkin variants in North American Parkinson's disease: cases and controls. Mov Disord (2003) 1.11
Utility of the national embryo morphology data collection by the Society for Assisted Reproductive Technologies (SART): correlation between day-3 morphology grade and live-birth outcome. Fertil Steril (2011) 1.10
Insulin resistance and impaired insulin secretion in prenatally androgenized male rhesus monkeys. J Clin Endocrinol Metab (2004) 1.09
Reporting of clinical outcomes in assisted reproductive technology. Fertil Steril (2013) 1.08
Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess. Fertil Steril (2002) 1.06
Early origins of polycystic ovary syndrome. Reprod Fertil Dev (2005) 1.05
Impaired developmental competence of oocytes in adult prenatally androgenized female rhesus monkeys undergoing gonadotropin stimulation for in vitro fertilization. J Clin Endocrinol Metab (2002) 1.04
McIndoe procedure for vaginal agenesis: long-term outcome and effect on quality of life. Am J Obstet Gynecol (2003) 1.03
Interaction of alpha-synuclein and tau genotypes in Parkinson's disease. Ann Neurol (2005) 1.01
High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy. Gynecol Oncol (2004) 1.01
Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women. Neurology (2013) 1.01
Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys. PLoS One (2011) 1.00
Gender and gonadal status differences in zona reticularis expression in marmoset monkey adrenals: Cytochrome b5 localization with respect to cytochrome P450 17,20-lyase activity. Mol Cell Endocrinol (2007) 1.00
Pioglitazone improves insulin action and normalizes menstrual cycles in a majority of prenatally androgenized female rhesus monkeys. Reprod Toxicol (2007) 0.99
Polycystic ovary syndrome and oocyte developmental competence. Obstet Gynecol Surv (2008) 0.98
The marmoset monkey: a multi-purpose preclinical and translational model of human biology and disease. Drug Discov Today (2012) 0.98
Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies. Brain (2012) 0.97
Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization. J Clin Endocrinol Metab (2006) 0.97
Characteristics of primary care office visits to nurse practitioners, physician assistants and physicians in United States Veterans Health Administration facilities, 2005 to 2010: a retrospective cross-sectional analysis. Hum Resour Health (2012) 0.96
Reproductive output, maternal age, and survivorship in captive common marmoset females (Callithrix jacchus). Am J Primatol (2004) 0.96
Effects of elevated circulating cortisol concentrations on maternal behavior in common marmoset monkeys (Callithrix jacchus). Psychoneuroendocrinology (2009) 0.96
Chemotherapy use and patient treatment preferences in advanced colorectal cancer: a prospective cohort study. Cancer (2012) 0.95
Reproductive skew in female common marmosets: what can proximate mechanisms tell us about ultimate causes? Proc Biol Sci (2009) 0.95
Predictors of vaginal relapse in stage I endometrial cancer. Gynecol Oncol (2005) 0.94
Hepatic resection for metachronous metastases from ovarian carcinoma. Gynecol Oncol (2003) 0.94
Post-conception reproductive competition in cooperatively breeding common marmosets. Horm Behav (2007) 0.94
Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes. Lung Cancer (2002) 0.93
Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems. BMC Cancer (2008) 0.93
Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.93
Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation. Steroids (2013) 0.93
Implications of polycystic ovary syndrome on oocyte development. Semin Reprod Med (2008) 0.92
Quality of colonoscopy reporting in community practice. Gastrointest Endosc (2010) 0.92
The epidemiology of tuberculosis among primary refugee arrivals in Minnesota between 1997 and 2001. J Travel Med (2007) 0.91
PCOS Forum: research in polycystic ovary syndrome today and tomorrow. Clin Endocrinol (Oxf) (2011) 0.91
Diminished cortisol levels in subordinate female marmosets are associated with altered central drive to the hypothalamic-pituitary-adrenal axis. Biol Psychiatry (2006) 0.91
MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies. Neurology (2013) 0.91
Factors that are associated with clinically overt postpartum urinary retention after vaginal delivery. Am J Obstet Gynecol (2002) 0.90
Common variants in PARK loci and related genes and Parkinson's disease. Mov Disord (2010) 0.90
Complex interactions in Parkinson's disease: a two-phased approach. Mov Disord (2003) 0.90
Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control study. Parkinsonism Relat Disord (2009) 0.90
Gonadotropin-releasing hormone II stimulates female sexual behavior in marmoset monkeys. Endocrinology (2005) 0.90
Acute doxorubicin insult in the mouse ovary is cell- and follicle-type dependent. PLoS One (2012) 0.89
Coffee, caffeine-related genes, and Parkinson's disease: a case-control study. Mov Disord (2008) 0.89
Case-control study of the alpha-synuclein interacting protein gene and Parkinson's disease. Mov Disord (2003) 0.89
Reduced intrafollicular androstenedione and estradiol levels in early-treated prenatally androgenized female rhesus monkeys receiving follicle-stimulating hormone therapy for in vitro fertilization. Biol Reprod (2003) 0.88
Living donor kidney transplantation using laparoscopically procured multiple renal artery kidneys and right kidneys. J Am Coll Surg (2013) 0.87
Flibanserin and 8-OH-DPAT implicate serotonin in association between female marmoset monkey sexual behavior and changes in pair-bond quality. J Sex Med (2012) 0.87
Insulin and messenger ribonucleic acid expression of insulin receptor isoforms in ovarian follicles from nonhirsute ovulatory women and polycystic ovary syndrome patients. J Clin Endocrinol Metab (2004) 0.87
Genomic determinants of motor and cognitive outcomes in Parkinson's disease. Parkinsonism Relat Disord (2012) 0.87
Male marmoset monkeys express an adrenal fetal zone at birth, but not a zona reticularis in adulthood. Endocrinology (2004) 0.87
Cutting edge: inhibiting measles virus infection but promoting reproduction: an explanation for splicing and tissue-specific expression of CD46. J Immunol (2002) 0.87
Beta-synuclein gene variants and Parkinson's disease: a preliminary case-control study. Neurosci Lett (2007) 0.85
UCHL1 is associated with Parkinson's disease: a case-unaffected sibling and case-unrelated control study. Neurosci Lett (2005) 0.85
Early-to-mid gestation fetal testosterone increases right hand 2D:4D finger length ratio in polycystic ovary syndrome-like monkeys. PLoS One (2012) 0.85
Variants in estrogen-related genes and risk of Parkinson's disease. Mov Disord (2011) 0.84
Can the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS) be used to accurately report clinic total reproductive potential (TRP)? Fertil Steril (2012) 0.83
Use of psychosocial support services among male Veterans Affairs colorectal cancer patients. J Psychosoc Oncol (2011) 0.82
Impact of urinary tract infection on allograft function after kidney transplantation. Clin Transplant (2014) 0.82
Elucidating the prognostic significance of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese patients with metastatic colorectal cancer. Asia Pac J Clin Oncol (2015) 0.82
Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. Endocrine (2012) 0.82
Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease. Mov Disord (2002) 0.81
Diminished maternal responsiveness during pregnancy in multiparous female common marmosets. Horm Behav (2004) 0.81
Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating hormone. Fertil Steril (2005) 0.80
Increased adiposity enhances intrafollicular estradiol levels in normoandrogenic ovulatory women receiving gonadotropin-releasing hormone analog/recombinant human follicle-stimulating hormone therapy for in vitro fertilization. J Clin Endocrinol Metab (2007) 0.80
Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study. BMC Cancer (2011) 0.80
Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis. Ann Transplant (2013) 0.80
Myeloperoxidase -463 (G-->A) polymorphism associated with lower risk of lung cancer. Mayo Clin Proc (2002) 0.80
Pulsatile gonadotropin-releasing hormone release from hypothalamic explants of male marmoset monkeys compared with male rats. Am J Physiol Regul Integr Comp Physiol (2009) 0.79
Factors underlying scalp-EEG interictal epileptiform discharges in intractable frontal lobe epilepsy. Epileptic Disord (2004) 0.79